Trials / Conditions / Advanced Squamous Non-Small Cell Lung Carcinoma
Advanced Squamous Non-Small Cell Lung Carcinoma
4 registered clinical trials studyying Advanced Squamous Non-Small Cell Lung Carcinoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint NCT06463665 | Genelux Corporation | Phase 2 |
| Unknown | TQB2450 Injection Combined With Chemotherapy Followed by Sequential Combination With Anlotinib Hydrochloride C NCT05718167 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 3 |
| Unknown | RBN-2397 in Combination With Pembrolizumab in Patients With SCCL NCT05127590 | Ribon Therapeutics, Inc. | Phase 1 / Phase 2 |
| Active Not Recruiting | CIMAvax Vaccine, Nivolumab, and Pembrolizumab in Treating Patients With Advanced Non-small Cell Lung Cancer or NCT02955290 | Roswell Park Cancer Institute | Phase 1 / Phase 2 |